Skip to main content
Fig. 4 | Diabetology & Metabolic Syndrome

Fig. 4

From: Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus

Fig. 4

Comparison of T lymphocyte subset counts and percentages among the four subgroups. DM, diabetes mellitus; non-DM, without diabetes mellitus; COVID-19, coronavirus disease 2019. a CD3+ā€‰Cell count. b CD3+ā€‰Cell percentage. c CD3+ā€‰CD4+ā€‰cell count. d CD3+ā€‰CD4+ā€‰cell percentage. e CD3+ā€‰CD8ā€‰+ā€‰cell count. f CD3+ā€‰CD8ā€‰+ā€‰cell percentage. G. Ratio of CD4ā€‰+ā€‰/CD8ā€‰+ā€‰cells. Unpaired one-way ANOVA was used for intergroup comparisons (a, c, P allā€‰<ā€‰0.0001; d Pā€‰<ā€‰0.01; e, f P allā€‰<ā€‰0.05). Unpaired t-tests was used for comparisons with the control group, *Pā€‰<ā€‰0.05, **Pā€‰<ā€‰0.01, ***Pā€‰<ā€‰0.001, ****Pā€‰<ā€‰0.0001

Back to article page